FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1557770367> ?p ?o ?g. }

• W1557770367 endingPage "64" @default.
• W1557770367 startingPage "157" @default.
• W1557770367 abstract "Drug resistance of lung cancer cells is one of main factors which affect the outcome of chemotherapy. It has been reported that abnormal p53 gene is well assosiated with chemotherapy resistance of tumor cells. The aim of this study is to evaluate the effects of p53 gene on drug resistance in human lung cancer cell lines, so as to provide foundation of choosing individual chemotherapy drugs in clinical treatment.The expression vectors which contain p53cDNA and p53 antisense cDNA respectively were constructed and were confirmed by sequencing. Transfected the 801D, a human lung cancer cell line with recombined plasmids by lipofectin mediating. Several kinds of monoclone cell lines, pEGFP-801D,pEGFP-sense p53-801D(including sense p53,pEGFP-p53(RS)-801D),pEGFP-antisense p53-801D(including antisense p53,pEGFP-p53(AS)-801D),which contained p53 of different status were obtained. Green fluorescence was observed through fluorescence microscopy. The extraneous gene was detected by PCR. MTT assay was taken to determine the drug resistance of each cell line to chemotherapy agents. Cell cycle and apoptosis induced by antitumor drugs were examined by flow cytometer.Extraneous sense p53 and antisense p53 were proved to be linked to plasmid respectively by sequencing.Green fluorescence was found in transfected cell lines. The IC50 of pEGFP-p53(AS)-801D cell line(0.26+/-0.09 mug/mL) to Cisplatin(DDP) decreased markedly compared with 801D(0.55+/-0.19 mug/mL,P<0.05)and pEGFP-801D(0.77+/-0.13mug/mL,P<0.05). The IC50 value of pEGFP-p53(RS)-801D to DDP is 0.43+/-0.25 mug/mL,which is significantly lower than that of pEGFP-801D(P =0.000)but higher than that of pEGFP-p53(AS)-801D(P <0.05). pEGFP-p53(RS)-801D cell line showed a notably smaller value of IC50(2.34+/-0.43 ng/mL) to Paclitaxel(TAX) than 801D(8.40+/-1.50 ng/mL, P <0.05)did. The IC50 value of pEGFPp53(RS)-801D is lower than that of pEGFP-801D(6.41+/-1.98 ng/mL),but not markedly. The IC50 of pEGFP-p53(RS)-801D cell line to 5-Fluorouracil(5FU) is 2.08+/-0.18 mug/mL, which is obviously lower than that of 801D(4.90+/-1.12 mug/mL,P <0.05) and pEGFP-801D(3.41+/-0.86 mug/mL,P <0.05). By the assay of flow cytometer, G2 phase arrest was observed when pEGFP-p53(AS)-801D was treated with DDP. TAX induced G2 phase arrest in pEGFP-p53(RS)-801D. A increased S phase proportion was induced by 5FU in pEGFP-p53(RS)-801D. The cell lines experienced apoptosis and necrosis when they were treated with either DDP or TAX.p53 gene of different status have different effects on resistance of chemotherapy agents in lung cancer cell lines. p53 mutation and deletion are related to drug resistance of DDP. p53 deletion connects with chemoresistance of TAX and 5FU. Neither p53 mutation nor p53 deletion is associated with drug resistance of Navelbine(NVB) and Gemcitabine(GEM). It is helpful to choose sensitive drugs according to the p53 status of patients for enhancing the efficiency of chemotherapy." @default.
• W1557770367 created "2016-06-24" @default.
• W1557770367 creator A5003085973 @default.
• W1557770367 creator A5015317090 @default.
• W1557770367 creator A5033497589 @default.
• W1557770367 creator A5036860312 @default.
• W1557770367 creator A5044506723 @default.
• W1557770367 creator A5051624923 @default.
• W1557770367 creator A5060591453 @default.
• W1557770367 creator A5072522693 @default.
• W1557770367 creator A5073651132 @default.
• W1557770367 creator A5090366405 @default.
• W1557770367 date "2008-04-20" @default.
• W1557770367 modified "2023-09-27" @default.
• W1557770367 title "[Effects of p53 gene on drug resistance in human lung cancer cell lines.]." @default.
• W1557770367 doi "https://doi.org/10.3779/j.issn.1009-3419.2008.02.001" @default.
• W1557770367 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20731894" @default.
• W1557770367 hasPublicationYear "2008" @default.
• W1557770367 type Work @default.
• W1557770367 sameAs 1557770367 @default.
• W1557770367 citedByCount "1" @default.
• W1557770367 countsByYear W15577703672018 @default.
• W1557770367 crossrefType "journal-article" @default.
• W1557770367 hasAuthorship W1557770367A5003085973 @default.
• W1557770367 hasAuthorship W1557770367A5015317090 @default.
• W1557770367 hasAuthorship W1557770367A5033497589 @default.
• W1557770367 hasAuthorship W1557770367A5036860312 @default.
• W1557770367 hasAuthorship W1557770367A5044506723 @default.
• W1557770367 hasAuthorship W1557770367A5051624923 @default.
• W1557770367 hasAuthorship W1557770367A5060591453 @default.
• W1557770367 hasAuthorship W1557770367A5072522693 @default.
• W1557770367 hasAuthorship W1557770367A5073651132 @default.
• W1557770367 hasAuthorship W1557770367A5090366405 @default.
• W1557770367 hasConcept C104317684 @default.
• W1557770367 hasConcept C111599444 @default.
• W1557770367 hasConcept C114851261 @default.
• W1557770367 hasConcept C142724271 @default.
• W1557770367 hasConcept C143141573 @default.
• W1557770367 hasConcept C147789679 @default.
• W1557770367 hasConcept C1491633281 @default.
• W1557770367 hasConcept C153911025 @default.
• W1557770367 hasConcept C185592680 @default.
• W1557770367 hasConcept C187882448 @default.
• W1557770367 hasConcept C190283241 @default.
• W1557770367 hasConcept C2776256026 @default.
• W1557770367 hasConcept C2776694085 @default.
• W1557770367 hasConcept C2778239845 @default.
• W1557770367 hasConcept C502942594 @default.
• W1557770367 hasConcept C54009773 @default.
• W1557770367 hasConcept C54355233 @default.
• W1557770367 hasConcept C71924100 @default.
• W1557770367 hasConcept C81885089 @default.
• W1557770367 hasConcept C86803240 @default.
• W1557770367 hasConceptScore W1557770367C104317684 @default.
• W1557770367 hasConceptScore W1557770367C111599444 @default.
• W1557770367 hasConceptScore W1557770367C114851261 @default.
• W1557770367 hasConceptScore W1557770367C142724271 @default.
• W1557770367 hasConceptScore W1557770367C143141573 @default.
• W1557770367 hasConceptScore W1557770367C147789679 @default.
• W1557770367 hasConceptScore W1557770367C1491633281 @default.
• W1557770367 hasConceptScore W1557770367C153911025 @default.
• W1557770367 hasConceptScore W1557770367C185592680 @default.
• W1557770367 hasConceptScore W1557770367C187882448 @default.
• W1557770367 hasConceptScore W1557770367C190283241 @default.
• W1557770367 hasConceptScore W1557770367C2776256026 @default.
• W1557770367 hasConceptScore W1557770367C2776694085 @default.
• W1557770367 hasConceptScore W1557770367C2778239845 @default.
• W1557770367 hasConceptScore W1557770367C502942594 @default.
• W1557770367 hasConceptScore W1557770367C54009773 @default.
• W1557770367 hasConceptScore W1557770367C54355233 @default.
• W1557770367 hasConceptScore W1557770367C71924100 @default.
• W1557770367 hasConceptScore W1557770367C81885089 @default.
• W1557770367 hasConceptScore W1557770367C86803240 @default.
• W1557770367 hasIssue "2" @default.
• W1557770367 hasLocation W15577703671 @default.
• W1557770367 hasLocation W15577703672 @default.
• W1557770367 hasOpenAccess W1557770367 @default.
• W1557770367 hasPrimaryLocation W15577703671 @default.
• W1557770367 hasRelatedWork W150926894 @default.
• W1557770367 hasRelatedWork W2030883789 @default.
• W1557770367 hasRelatedWork W2352258017 @default.
• W1557770367 hasRelatedWork W2355678225 @default.
• W1557770367 hasRelatedWork W2364319975 @default.
• W1557770367 hasRelatedWork W2378289917 @default.
• W1557770367 hasRelatedWork W2384261171 @default.
• W1557770367 hasRelatedWork W2386240997 @default.
• W1557770367 hasRelatedWork W2391655816 @default.
• W1557770367 hasRelatedWork W2410597369 @default.
• W1557770367 hasVolume "11" @default.
• W1557770367 isParatext "false" @default.
• W1557770367 isRetracted "false" @default.
• W1557770367 magId "1557770367" @default.
• W1557770367 workType "article" @default.